{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:33:08Z","timestamp":1649161988486},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jogoh.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T20:17:44Z","timestamp":1486153064000},"page":"249-254","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?"],"prefix":"10.1016","volume":"46","author":[{"given":"A.-G.","family":"Pourcelot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Capmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2017.02.001_bib0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jgyn.2014.06.001","article-title":"[Epidemiological data for uterine fibroids in France in 2010\u20132012 in medical center--analysis from the French DRG-based information system (PMSI)]","volume":"43","author":"Fernandez","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0145","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jgyn.2014.07.006","article-title":"[Prevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30\u201355 years]","volume":"43","author":"Fernandez","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1471-0528.2002.01225.x","article-title":"Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review","volume":"109","author":"Lethaby","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0155","first-page":"CD010854","article-title":"Add-back therapy with GnRH analogues for uterine fibroids","author":"Moroni","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00016348509155136","article-title":"Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium","volume":"64","author":"Tamaya","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0185","first-page":"123","article-title":"Physiopathologie des fibromes","volume":"11","author":"Christin-Maitre","year":"2009","journal-title":"Med Reprod Gynecol Endocrinol"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0190","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.steroids.2003.08.017","article-title":"Effects of progesterone on growth factor expression in human uterine leiomyoma","volume":"68","author":"Maruo","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0195","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2012.02.021","article-title":"The immninent dawn of SPRMs in obstetrics and gynecology","volume":"358","author":"Chabbert-Buffet","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0215","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0220","first-page":"774","article-title":"[Epidemiology and risk factors for cancer of the uterus]","volume":"64","author":"Bonneau","year":"2014","journal-title":"Rev Prat"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0225","first-page":"159","article-title":"Endometrial effects of prolonged therapy with the selective progesterone receptor modulator ulipristal acetate: a case report","volume":"61","author":"Levy","year":"2016","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejogrb.2016.11.003","article-title":"Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results","volume":"208","author":"Fernandez","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0235","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.fertnstert.2014.07.1253","article-title":"First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids","volume":"102","author":"Luyckx","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0240","first-page":"496","article-title":"Pre-treatment with ulipristal acetate before ICSI procedure: a case report","volume":"6","author":"Wdowiak","year":"2013","journal-title":"Przeglad Menopausalny"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0245","first-page":"3145","article-title":"Successful pregnancy after treatment with ulipristal acetate for uterine fibroids","volume":"2014","author":"Monleon","year":"2014","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jogc.2015.11.004","article-title":"Spontaneous pregnancy following ulipristal acetate treatment in a woman with a symptomatic uterine fibroid","volume":"38","author":"Murad","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0255","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(11)61381-0","article-title":"Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study","volume":"378","author":"Musallam","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jogoh.2017.02.001_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130861","article-title":"Impact of preoperative anaemia and blood transfusion on postoperative outcomes in gynaecological surgery","volume":"10","author":"Richards","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717300259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717300259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T16:52:44Z","timestamp":1536079964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784717300259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2468784717300259"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.02.001","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}